We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments... Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. Show more
PITTSBURGH, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the βCompanyβ) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate...
PITTSBURGH, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the βCompanyβ) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate...
DΓ©colletΓ© indication selected for Phase 2 study expected to start next year Conference call to discuss results scheduled for Wednesday, August 28, 2024 at 4:30 p.m. ET PITTSBURGH, Aug. 28, 2024...
Net product revenue of $70.3 million in 2Q and $166.2 million since launch in August 2023 On track to deliver three clinical readouts in 2H 2024Jeune Aestheticsβ KB301 Phase 1 PEARL-1 study...
U.S. index futures fell sharply after a volatile week, with the Nasdaq Composite entering correction territory due to recession concerns and uncertainties about Federal Reserve actions. At 04:37...
PITTSBURGH, July 26, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the βCompanyβ) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its second...
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK, June 7, 2024 NEW YORK, June 7, 2024 /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -5.49 | -2.96612458804 | 185.09 | 187.34 | 176.225 | 262358 | 181.5016767 | CS |
4 | -17.74 | -8.98956116347 | 197.34 | 204.11 | 176.225 | 263601 | 188.32530002 | CS |
12 | 3.6 | 2.04545454545 | 176 | 219.34 | 164.81 | 267682 | 193.68436635 | CS |
26 | 4.71 | 2.69312139059 | 174.89 | 219.34 | 144.0001 | 324082 | 179.7798537 | CS |
52 | 63.35 | 54.4946236559 | 116.25 | 219.34 | 93.95 | 336635 | 153.49916293 | CS |
156 | 123.02 | 217.426652527 | 56.58 | 219.34 | 38.8563 | 273801 | 111.51530948 | CS |
260 | 138.43 | 336.239980568 | 41.17 | 219.34 | 31.89 | 222670 | 96.42067626 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions